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a  b  s  t  r  a  c  t
Post-weaning  multi-systemic  wasting  syndrome  (PMWS)  is  a multi-factorial  disease  with
major  economic  implications  for  the  pig  industry  worldwide.  The  present  study  aimed
to assess  the  economic  impact  of  PMWS  and  porcine  circovirus  type  2  (PCV2)  subclinical
infections  (PCV2SI)  for  farrow-to-ﬁnish  farms  and  to  estimate  the  resulting  cost  to  the
English  pig  industry.
A  disease  model  was  built  to simulate  the  varying  proportions  of pigs  in  a batch  that  get
infected  with  PCV2  and  develop  either  PMWS,  subclinical  disease  (reduce  growth  without
evident  clinical  signs)  or remain  healthy  (normal  growth  and  no  clinical  signs),  depending
on  the  farm  level  PMWS  severity.  This  PMWS  severity  measure  accounted  for  the  level  of
post-weaning  mortality,  PMWS  morbidity  and  proportion  of  PCV2  infected  pigs  observed
on farms.  The  model  generated  six outcomes:  infected  pigs  with  PMWS  that  die  (PMWS-
D); infected  pigs  with  PMWS  that  recover  (PMWS-R);  subclinical  pigs  that die  (Sub-D);
subclinical  pigs  that  reach  slaughter  age  (Sub-S);  healthy  pigs  sold  (H-S);  and  pigs,  infected
or non-infected  by  PCV2,  that  die  due  to non-PCV2  related  causes  (nonPCV2-D).  Enterprise
and  partial  budget  analyses  were  used  to  assess  the  deﬁcit/proﬁts  and  the  extra  costs/extra
beneﬁts of a change  in  disease  status,  respectively.  Results  from  the  economic  analysis  at
pig level  were  combined  with  the  disease  model’s  estimates  of  the  proportion  of  different
pigs  produced  at different  severity  scores  to  assess  the  cost  of PMWS  and subclinical  disease
at farm  level,  and  these  were  then  extrapolated  to estimate  costs  at national  level.
The  net  proﬁt  for a H-S  pig  was  £19.2.  The  mean  loss  for a PMWS-D  pig  was  £84.1  (90%
CI:  79.6–89.1),  £24.5  (90%  CI: 15.1–35.4)  for a PMWS-R  pig,  £82.3 (90%  CI: 78.1–87.5)  for a
Sub-D  pig,  and  £8.1  (90%  CI:  2.18–15.1)  for  a Sub-S  pig.  At farm  level,  the  greatest  proportion
of negative  economic  impact  was  attributed  to  PCV2  subclinical  pigs.  The  economic  impact
for  the  English  pig  industry  for the  year  2008,  prior  to  the introduction  of  PCV2 vaccines,
was  estimated  at £52.6 million  per  year  (90%  CI:  34.7–72.0),  and  approximately  £88  million
per  year  during  the  epidemic  period.
This was  the  ﬁrst study  to use empirical  data  to model  the  cost  of  PMWS/PCV2SI  at
different  farm  severity  levels.  Results  from  this  model  will  be used  to assess  the  efﬁciency
of different  control  measures  and  to provide  a  decision  support  tool  to  farmers  and  policy
makers.
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1. Introduction
In 1996 post-weaning multi-systemic wasting syn-
drome (PMWS) was ﬁrst described based on cases
occurring in 1991 in Canada (Harding, 1996). Pigs affected
by the disease were aged 8–16 weeks and showed wast-
ing or growth retardation, pallor of the skin, respiratory
signs and, occasionally, intermittent diarrhoea (Harding
and Clark, 1997). Porcine circovirus type 2 (PCV2) was  con-
ﬁrmed to be the necessary pathogen (LeCann et al., 1997;
Nayar et al., 1997; Allan et al., 1998). Since then, the disease
has been observed in most pig producing countries world-
wide. However, it has been shown that the presence of
PCV2 alone is not enough to trigger clinical signs. Other fac-
tors, such as co-infections or environmental conditions and
management practices leading to stress and/or increased
infectious pressure are believed to be necessary (Madec
et al., 2000). The recent successful implementation of PCV2
vaccinations suggest that a subclinical form of the disease
was also highly prevalent across farms, as improvement of
productivity was higher than could be expected based on
clinical PMWS  alone (Kurmann et al., 2011; Young et al.,
2011). The criterion for the individual diagnosis of PCV2
subclinical pigs (PCV2SI) includes: (1) decrease of average
daily gain with no clear clinical signs, (2) no or minimal
histiopathological lesions in tissues and (3) presence of low
amount of PCV2 in tissues (Segales, 2011b). Opriessnig et al.
(2006) showed that PCV2 subclinical infection decreased
the efﬁcacy of PRRS vaccine and later hypothesized that
PCV2 subclinical infected pigs could have higher suscepti-
bility to other pathogens (Opriessnig et al., 2007). In order
to account for the effects of PCV2 infection in epidemiologi-
cal studies, an approach to deﬁne PMWS  severity categories
at farm level was recently described (Alarcon et al., 2011b).
However, despite the acknowledged importance of subcli-
nical pigs, the quantiﬁcation and the economic impact of
these subclinical pigs has not been investigated yet.
Before PCV2 vaccines were available, PMWS  had an
enormous impact on the productivity on the most of pig
industries worldwide (Gillespie et al., 2009). In Europe,
during the epidemic stage from 1996 to around 2004, on
farm morbidity rates as high as 50–60% and post-weaning
mortality between 4 and 20% were reported (Madec et al.,
2000; Segales and Domingo, 2002). As the disease became
endemic, middle to late 00s, observed morbidity varied
considerably between 1% and 30%, while post-weaning
mortality remained an important factor for the diagnosis
of PMWS  at farm level. In England the average post-
weaning mortality for non/slightly, moderately and highly
PMWS affected farms was  3.7%, 7.3% and 13.5% respectively
(Alarcon et al., 2011b). However, despite the major impact
of the disease in the industry, no structured economic anal-
ysis or disease impact assessment has investigated the
economic importance of PMWS.  Very few studies have pro-
vided an estimation of the cost of this disease. For example,
in the United Kingdom the cost of PMWS  was estimated at
£35 million per year based on crude numbers of pigs dead
and not sent to slaughter (Armstrong and Bishop, 2004).
Using the same approach and with data extrapolated from
the Netherlands, with a 4% reduction in pigs slaughtered
due to PMWS,  the cost of the disease for the European Union Medicine 110 (2013) 88– 102 89
was estimated to be between D 562 and D 900 million per
year (Tucker, 2006). These estimations were only done at
industry level for the epidemic period and did not consider
the full cost and the complexity of this disease, as only the
revenue missed due to PMWS  dead pigs were calculated
and the costs and losses suffered from subclinical pigs were
not included. Recently, a study based on PCV2 vaccination
trials, investigated the cost-effectiveness of vaccination
in farms affected by porcine circovirus associated disease
(PCVAD). The economic model was  based on the fact that
an infected herd loses 2.5 kg per pig produced plus 0.5 kg
per 1% additional mortality due to PCVAD (Burch, 2010).
Although this model accounted for losses from subclinical
pigs, clinical pigs dying from the disease and clinical pig not
dying, only the revenue from the kg missed to produced
were considered and no difference in cost between clinical
and subclinical infection was  obtained.
Assessment of the economic burden of PMWS  and
PCV2SI is essential to investigate and identify the most
cost-effective control strategies and to prioritize the use
of scarce resources. In an endemic situation, severity of
PMWS  and its associated costs can vary considerably across
farms (Alarcon et al., 2011b). This indicates a variability
of disease importance and that different control measures
will differ in efﬁciency. Control measures that are economi-
cally efﬁcient in some situations might not be economically
efﬁcient in others situations. Therefore, understanding the
economic impact of PMWS  and PCV2SI is the necessary and
essential ﬁrst step to optimize control of these diseases. The
aim of the current study was  to develop an economic model
to estimate disease losses at farm level for different PMWS
severities. In addition, the study also aims to differentiate
between costs and losses from clinical and subclinical pigs.
2. Materials and methods
An epidemiological disease model was  built to simulate
the disease events occurring in a farm at different PMWS
severity levels. Economic costs and beneﬁts were calcu-
lated separately for the different categories of infected,
diseased and healthy pigs. These were then applied to the
epidemiological model in order to obtain the overall eco-
nomic impact of PMWS  and PCV2SI. Four data sources were
used to build the epidemiological and the economic model:
• Cross-sectional study of 147 English farms carried out in
2008/2009 (CS-2008): Farms in this study were recruited
through the PCV2 vaccination programme launch by
BPEX in April 2008. However, in order to ensure repre-
sentativeness of the sample, several farms less affected by
PMWS  were recruited through veterinary practitioners.
All farms were PCV2 unvaccinated at the time of the visit.
In each farm 20 blood samples (6 weaners, 6 growers, 6
ﬁnishers and 2 sows) were collected and tested for PCV2
by PCR. In addition, data on production performance and
on six PMWS  morbidity variables were collected (Alarcon
et al., 2011b).• Longitudinal study conducted between 1999 and 2001
(L-2001): This study was  conducted in a commercial
farm with research facilities in the United Kingdom; nine
batches of pigs (n = 1080 pigs) were followed over time
9 terinary
•
•
2
t
(
a
1
m
s
b
m
T
1
b
w
b
b
w
i
b
2
t0 P. Alarcon et al. / Preventive Ve
in an experimental study that tried to assess the impact
of different air environment conditions in the health and
growth of the pigs (Wathes et al., 2004). Each batch was
composed of 120 weaners that were allocated to 5 rooms
(24 pigs per room) with different environmental condi-
tions. Over 5 weeks pig weights and feed intake were
monitored at animal and pen level, respectively. In addi-
tion, blood samples from 371 pigs were available for
testing for PCV2 antigen through PCR. Halfway through
the experiment the farm was hit by an outbreak of PMWS
and affected batches 7–9 (Wieland et al., 2012). Subse-
quently data of PMWS  pigs and PCV2 infected pigs of
batches 8 and 9 were collected and provided the basis
to derive feed conversion ratios (FCR) and growth rates.
Farmer opinion survey conducted in 2011 (FO-2011):
Twenty farmers were visited after the ﬁrst version of the
epidemiological and economic model was built. Farms
were selected randomly from the BPEX PCV2 vaccination
programme database. Model uncertainties and assump-
tions were addressed through farmer’s interview and
using open and closed questions, i.e. data on PMWS
fatality rate, veterinary and labour cost associated with
PMWS,  and possible slaughterhouse penalty on carcasses
from PMWS  recovered pigs were collected.
UK pig industry benchmarking data: Collected for the
years 2009 and 2010 (Bench09 and Bench10) for the base-
line construction of the model (Anonymous, 2010, 2011).
These data were collected by BPEX from farms using
the Agrosoft recording software (Agrosoft Ltd., Yew Tree
Farm, United Kingdom). For the analysis of the historical
economic impact of the disease, some parameters in the
benchmarking data from the year 2001–2008 (Bench1
to Bench08) were used to adapt the economic model to
each year economic situation (i.e. pig prices, feed prices,
etcetera).
.1. PMWS  severity case deﬁnition
A PMWS  severity score was obtained using data from
he CS-2008 study with a method described in Alarcon et al.
2011b). Brieﬂy, in a ﬁrst step, six PMWS  morbidity vari-
bles were summarised into two factors: morbidity factor
 (MF1, morbidity observed in weaners and growers), and
orbidity factor 2 (morbidity observed in ﬁnishers). Sub-
equently, a farm level PMWS  severity score was  obtained
y combining data on PCV2 PCR results, post-weaning
ortality and MF1, using principal component analysis.
he derived PMWS  severity score ranged between 0 and
0. Farms that scored lower than 4 were considered to
e slightly affected; farms with scores higher than 6.5
ere classiﬁed as highly affected; and farms that scored
etween 4 and 6.5 were considered as moderately affected
y PMWS.  In the cross-sectional study, from the 110 farms
ith complete and reliable data, 27, 58 and 25 farms were
dentiﬁed as ‘Non/Slightly’, ‘Moderately’ or ‘Highly’ affected
y PMWS,  respectively..2. PMWS  within-farm epidemiological model
The epidemiological model assumed that PCV2 infec-
ion in a pig could lead to (1) typical PMWS  clinical signs, (2) Medicine 110 (2013) 88– 102
to reduced growth but with no evident clinical sign or (3) to
normal growth and no clinical sign (Fig. 1). The latter type of
pigs were assumed to not have any cost or economic impact
to the farmer. Therefore, for simplicity, in this manuscript
‘subclinical pigs’ are pigs that are infected by PCV2, have
reduced growth rates, but no evident clinical signs. This
deﬁnition of ‘subclinical pigs’ was suggested by Segales
(2011b). The deﬁnitions and acronyms of the different type
of pigs used in this study can be found in Table 1. The pro-
portion of each type of pig in a batch depends on the PCV2
prevalence, PMWS  morbidity and the post-weaning mor-
tality of the farm, and therefore on the PMWS  severity of the
farm.
2.2.1. Model parameters and data ﬁtting for the
epidemiological model
2.2.1.1. Time to slaughter (t1, t2 and t3), growth rates and
reduction in daily feed consumption. The reference param-
eters used for healthy pigs were obtained from the English
pig industry benchmarking data 2010. In order to get a
realistic estimation for values of a healthy pig, only data
from the top third farms were used: a healthy pig was
weaned at 28 days with a liveweight of 8.1 kg, remained
140 days in feed (t1) and was sent to slaughter with at a live
weight of 102.6 kg, equal to an average daily gain (ADG) of
0.675 kg/day.
The growth rate parameters used for diseased pigs
were derived from data from the two  batches of pigs
that had PMWS  in the L-2001 study. Pigs in this exper-
iment were divided into three categories: (1) non-PCV2
infected pigs, (2) PCV2 infected pigs not showing PMWS
clinical signs and (3) PCV2 infected pigs showing PMWS
clinical signs. Signiﬁcance of differences in growth rates
(between weaning and day 41 in the experiment) of
the three types was assessed through the use of t-tests.
Reduction in growth rates for PMWS  and other PCV2
infected pigs, compared to non-PCV2 infected pigs, were
transformed into percentage (% ADG reduction). These
percentages were then applied to the reference parame-
ters used for healthy pigs in order to obtain the model
ADG for PMWS  and PCV2 subclinical pigs. In the case of
PMWS-R, it was assumed that the growth rate after recov-
ering from PMWS  clinical condition was  the same as the
growth rate of a subclinical pig. The time needed for a
PMWS-R (t3) and Sub-S (t2) to reach the required slaugh-
ter deadweight were obtained using the calculated growth
rates.
To assess the appetite loss of a PMWS  pig and the
reduction in daily feed consumption of a PCV2SI pig, data
from the L-2001 study were used. In a linear regression
analysis, using data of batches 8 and 9 only, a signiﬁ-
cant association (p-value < 0.0001, R2 = 0.60) was obtained
between the pen level average daily weight gains (exposure
variable) and the pen level average daily feed consump-
tion (DFC) (outcome variable), adjusted for pen mortality.
Using the linear regression function, the daily feed con-
sumption rate was predicted for a pen with (1) pigs
with ADG equal to the non-PCV2 infected pigs, (2) pigs
with ADG equal to the PCV2 infected pigs not show-
ing PMWS  symptoms, and (3) pigs with ADG equal to
the PCV2 infected pigs showing PMWS  symptoms. The
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Fig. 1. Structure of epidemiological within-farm PMWS disease model.
Table 1
Acronyms and deﬁnitions for the different types of pigs used in the economic model. It is important to note that a proportion of H-S pigs are also infected
by  PCV2. However, these pigs were assumed to not have any economic impact for the farmer. Therefore, the acronym ‘PCV2SI’ in this study only refers to
the  combination of Sub-D and Sub-S.
Type of pigs in the model Deﬁnition Group classiﬁcation
PMWS-D PCV2 infected pig that develops PMWS clinical signs causing death or the
necessity of being culled
PMWS  pigs
PMWS-R PCV2 infected pig that develops PMWS clinical signs, but is able to recover,
resulting in delayed slaughter (t3 − t1).
Sub-D PCV2 infected pig, that shows no clinical PMWS,  but that has a reduced growth
rate and increased susceptibility for co-infection with other pathogens,
leading to death.
Subclinical pigs (PCV2SI)
Sub-S  PCV2 infected pig that shows no clinical PMWS,  but has a reduced growth rate
and reduced feed intake. This pig will take longer (t2 − t1) to reach the
required weight at slaughter.
H-S Pig, infected or not infected by PCV2, that remains healthy throughout its life,
with normal growth and reaches age to slaughter at t1.
Healthy pig sold
y PCV2 
e pigs isNonPCV2-D These pigs can either be non infected b
PMWS  clinical signs. The death of thes
differences obtained in DFC between pens were trans-
formed into percentages and represented the appetite
loss of PMWS pigs and DFC reduction of subclinical pigs
(Appendix 1).
2.2.1.2. Proportion of each type of pig in a batch for a given
PMWS  severity. In order to assess the proportion of each
type of pig at different PMWS  severity levels, it was impor-
tant to determine how mortality, morbidity and number of
infected pigs increase with an increase in PMWS  severity.
Therefore, data on post-weaning mortality and proportion
of PCV2 infected pigs collected during the CS-2008 study
were ﬁtted to the epidemiological model through non-
linear regression analysis and mean values for each variable
at each PMWS  severity level were obtained. Level of PMWSMF1  = e
(PMWS severity/4.5) − postweaning mortal
0or infected by PCV2 but with no
 not due to PCV2 infection.
Pig that dies due to non-PCV2
related causes
morbidity (MF1) at each severity was  then calculated with
the Equation 1, which was derived from Alarcon et al.
(2011b). In this case, MF1  is a factor score derived from six
PMWS  morbidity variables, where the variable ‘percentage
of PMWS  cases in growers’ presented the highest loading.
Therefore, in order to obtain the mean percentage of PMWS
cases in a batch at different PMWS  severity levels, a non-
linear regression was  also performed using ‘percentage of
PMWS  cases in growers’ as the outcome variable and MF1
as the predictive variable. Details of the non-linear regres-
sion models are shown in Table 2 in the corresponding vari-
ables. Once the mean overall post-weaning mortality, mean
PMWS  morbidity, and mean percentage of PCV2 infected
pigs were obtained for each PMWS  severity, the proportion
of each type of pig in a batch was  calculated as follows:ity ∗ 0.5752 − PCV2 infected ∗ 0.5259 − 3.48
.6266
(1)
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Table 2
Parameters for the economic disease model. Where: H-S are healthy pigs with normal growth; PMWS-D are PMWS  pigs that die due to the disease; PMWS-R
are  PMWS  pigs that recover from the disease; Sub-D are PCV2 infected pigs with slow growth, no clear PMWS  clinical sign and that die; and Sub-S are PCV2
infected pigs with slow growth, no clear PMWS  clinical sign and that survive.
Parameters Symbol Value Stochastic Reference
Distribution Range
Post-weaning mortality
Overall post-weaning mortality XT 1.29*exp(0.313*PMWS
severity)
Normal 0.27–0.36 Fitted through non-linear
regression of CS-2008 data (reg
coef. p < 0.01, R2 = 0.88). The
95% conﬁdence interval of the
regression coefﬁcient was used
to deﬁne the stochastic range.
Post-weaning mortality
non-PCV2 related (%)
X2+3 3.08 – – Post-weaning mortality at
severity of 2.79 (see
assumption 7 in Table 3)
Post-weaning mortality
attributable to PMWS  pigs
X5  *FR – – [Rule: Cannot be higher than
the proportion of PCV2
infected pigs]
PMWS  fatality rate (FR) FR 1.0136*exp(−0.0382* ) – – Fitted through non-linear
regression of FO-2011 data (reg
coef. p = 0.17, R2 = 0.82)
Post-weaning mortality
attributable to PCV2 subclinical
pigs
X4 XT − X2+3 − X5 – – [Rule: X4 cannot be less than
zero]
PMWS  morbidities and PCV2
prevalence
– –
Proportion of PCV2 infected
pigs
 0.0982*exp(0.2244*PMWS
severity)
Normal 0.18–0.27 Fitted through non-linear
regression of CS-2008 data
(p < 0.01, R2 = 0.87). The 95%
conﬁdence interval of the
regression coefﬁcient was used
to deﬁne the stochastic range.
Percentage of PMWS  pigs   0.1127*exp(2.8802*MF1) Normal 2.61–0.15 Fitted through non-linear
regression of CS-2008 data
(p < 0.01, R2 = 0.82)). The 95%
conﬁdence interval of the
regression coefﬁcient was used
to deﬁne the stochastic range.
Morbidity factor 1 MF1  See Eq. (1) – –
Proportion of PCV2 infected
pigs that develop subclinical
signs
˝ 0.73 Normal 0.27–0.48 Estimated from data of L-2001
(see assumption 3 in Table 3).
The 95% conﬁdence interval
was used to deﬁne the
stochastic range.
Growth rate parameters
Average weight at slaughter of
a  H-S pig (kg)
Wt1 102.6 – – T1*ADGH-S + Wt0
Average weight at weaning of a
H-S pig (kg)
Wt0 8.1 – – Bench10
Average daily weight gain of a
H-S pig (kg/day)
ADGH-S 0.675 – – Bench10
Percentage reduction in ADG of
a  Sub-S pig
Sub 16 Normal 3–29 Estimated from data of L-2001
study. The 95% conﬁdence
interval was  used to deﬁne the
stochastic range.
Average daily weight gain of a
Sub-S pig (kg/day)
ADGSub 0.567 – – ADGH-S*(1 − Sub)
Percentage reduction in ADG of
a  PMWS-R pig
PMWS 26 Normal 16–36 Estimated from data of L-2001
study. The 95% conﬁdence
interval was  used to deﬁne the
stochastic range.
Average daily weight gain of a
PMWS-R pig (kg/day)
ADGPMWS 0.500 – – ADGH-S*(1 − PMWS)
Average weight at death of a
PMWS-D pig (kg)
WPMWSD 30.37 – – Wt0 + TPMWSD*ADGPMWS
Average weight at death of a
Sub-D pig (kg)
WSubD 42.12 – – Wt0 + TSubD*ADGSub
Time parameters
Average days in feed of a H-S
pig (days)
T1 140 – – Bench10
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Table 2 (Continued)
Parameters Symbol Value Stochastic Reference
Distribution Range
Average days in feed of a Sub-S
pig (days)
T2 166.67 – – (Wt1 − Wt0)/ADGSub [161 days
in the model as explained in
assumption 8, Table 3)
Average days in feed of a
PMWS-D pig (days)
TPMWSD 56 Beta pert 42–70 See assumption 6, Table 3
Average days in feed of a Sub-D
pig (days)
TSubD 56 Uniform 50–80 See assumption 6, Table 3
Average days in feed of a
PMWS-R pig (days)
T3 173.81 – – ((TPMWSD) + ((WHS − WPMWSD)/ADGSub)
Breeding parameters
Litters per sow per year LSY 2.2 – – Bench10
Pigs  born alive per sow per
litter
PBSL 11.20 – – Bench10
Mortality of pigs born alive (%) X1 12.72 – – Bench10
Pigs  weaned er sow per year WSY  21.99 – – LSY*PBSY*(1 − (X1/100))
Sow  year replacement rate (%) SRR 49.25 – – Bench10
Average number of parities AP 4.56 – – (100/SRR)*LSY
Cost  of replacing a gilt (£) CG 157.62 – – Bench09
Feed  parameters
Sow feed consumption per
year (kg)
FQS 1232 – – Bench10
Sow  feed price/tonne (£) FPS 162.87 – – Bench10
Grower feed price/tonne (£) FPG 202.55 – – Bench10
Feed  conversion of a H-S pig FCRHS 2.39 – – Bench10
Feed  consumed per H-S pig
(kg)
FQHS 225.85 – – FCRHS*(Wt1 − Wt0)
Feed  consumed per day per
H-S pig (kg)
DFQHS 1.61 – – FQHS/T1
Appetite loss of a PMWS-D and
PMWS-R pigs during the
clinical stage (%)
ALPMWS 17 Linked to
PMWS
Linked to
PMWS
Estimated from data of L-2001
study trough the correlation
observed between feed intake
and average daily gain at pen
level. See Appendix 1.
Reduction in feed consumption
by  subclinical pigs (%)
ALSub 10 Linked to
Sub
Linked to
Sub
Estimated from data of L-2001
study trough the correlation
observed between feed intake
and average daily gain at pen
level. See Appendix 1.
Feed  consumed per PMWS-D
pig (kg)
FQPMWSD 79.37 – – DFQHS*(1 − (ALPMWS/100))*TPMWSD
Feed consumed per Sub-D pig
(Kg)
FQSubD 104.86 – – DFQHS*TSubD
Feed consumed per PMWS-R
pig (kg)
FQPMWSS 242.31 – – FQPMWSD + (DFQHS*(T3 − TPMWSD)
Feed  consumed per Sub-S pig
(kg)
FQSubS 259.72 – – DFQHS*T2
Other parameters
Veterinary multiplication
factor
VMF  2.74 Beta pert 1–8.06 Average obtained from
FO-2011 study. Minimum and
maximum values obtained
were used to deﬁne the
stochastic range.
Cost  of disposing a dead
carcass (£)
DC 6 – – As reported by a farmer in the
FO-2011 study.
Penalty on PMWS carcass
(pp/kg)
PC 8.75 Beta pert 0–35 Average obtained from
FO-2011 study. Minimum and
maximum values obtained
were used to deﬁne the
stochastic range.Deadweight average pig price
(£/kg)
DAPP 1.39 • Percentage of nonPCV2-D:  assumed to be equal to the
overall post-weaning mortality obtained in an average
PMWS  none or slightly affected farm (see assumption 1
in Table 3).– – Bench10• Percentage of PMWS-D: derived from the overall number
of PMWS  cases and the PMWS  fatality rate in each PMWS
severity score (Eq. (2) and see fatality rate assumption in
Table 3).
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Table 3
Main assumptions made on the epidemiological and economic model. Where: H-S are healthy pigs with normal growth; PMWS-D are PMWS  pigs that die
due  to the disease; PMWS-R are PMWS  pigs that recover from the disease; Sub-D are PCV2 infected pigs with slow growth, no clear PMWS  clinical sign
and  that die; and Sub-S are PCV2 infected pigs with slow growth, no clear clinical sign and that survive.
N Assumptions Justiﬁcation
1. The PMWS  fatality rate is not constant. It is
assumed to be high (100%) when few cases are
observed and decreases when the number of
cases increases substantially.
This study assumes that the farmer will try to recover as many pigs as possible
when the number of cases is high. The validity of this assumption was
investigated with the data collected in the FO-2011 (data not shown). The
reduction in fatality rate used for this study was calculated by ﬁtting this data
into the model.
2.  Percentage of PCV2 PCR positive pigs was used
as  PCV2 prevalence for each PMWS  severity
score.
Due to lack of prevalence data in relation to PMWS  severity scores, this
proportion was assumed to be a reasonable approximation of the PCV2
prevalence at farm level.
3  73% of non-PMWS PCV2 infected pigs develop
subclinical signs (˝). This measure is constant
at  any PMWS  severity score.
This was  estimated using the L-2001 study. In that study 73% of infected pigs,
not  showing PMWS  clinical signs, had an ADG below the lower 95% conﬁdence
interval level of non-PCV2 infected pigs.
5  A PMWS-R pig after recovering has an ADG
equal to the PCV2 subclinical pig.
The retardation in growth suffered during the clinical stage makes the pig
unable to grow at a normal healthy speed when they recover from the disease.
6  A PMWS-R pig recovers and a PMWS-D pig
dies 56 days after weaning; a Sub-D pig dies at
56 days in feed.
The window of PMWS  is between 8 and 16 weeks of age, therefore 12 weeks
was chosen as the average age of death or recovery of a PMWS  pig. To adjust
for uncertainty the age at death/recovery of a PMWS  pig was varied by 2
weeks in the stochastic model. The age of death of a Sub-D was also varied in
the stochastic model to account for uncertainty (see Table 2)
7  The non-PCV2 related post-weaning mortality
(X2) is assumed to be equal to the level of
post-weaning mortality observed in an average
slightly affected farm with a PMWS  score of
2.79
Farms with PMWS scores below the average slightly affected severity score
(2.79) are assumed to be free of PMWS  or with insigniﬁcant morbidity levels.
Although few subclinical pigs may  be present, no death due to PCV2 occurs.
8  Sub-S pigs are not detected by the farmer or
the vet and therefore are treated like H-S pigs,
but they need more time to reach the slaughter
weight.
Subclinical per se is not easy to detect by farmers or vets, as no clinical signs
are shown. Although these pigs are more susceptible to other pathogens, it
was assumed that the condition is not detected by the farmer or the vet.
The ﬁxe
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o9  Fixed costs were assumed to be equal to all the
farms in industry level analysis.
PMWS-D = PMWS  morbidity ∗ Fatality rate (2)
Percentage of PMWS-R: represented the remaining PMWS
cases (overall number of PMWS  cases minus fatalities due
to PMWS).
Percentage of Sub-D:  equal to the post-weaning
mortality that was not due to PMWS-D or
nonPCV2-D.
Percentage of Sub-S: calculated using Eq. (3):
Sub-S = (PCV2 prevalence − PMWS  morbidity)  ∗  ˝ (3)
here  ˝ was the proportion of non-PMWS PCV2 infected
igs that have reduced growth rates (see assumption 3 in
able 3).
.3. PMWS  economic model
.3.1. Individual economic analysis
In order to assess the economic impact of disease on
ach type of pig (H-S, PMWS-D, PMWS-R, Sub-D and Sub-
) two types of economic analyses were carried out: (1) an
nterprise budget analysis (EBA) and (2) a partial budget
nalysis (PBA). However, it is important to ﬁrst clarify the
ifferences and the relationship between these two  types
f analyses.d costs used were obtained from the English pig industry
arking data and represent the average ﬁxed costs of farms.
Rushton (2009) deﬁned EBA as an estimate of the differ-
ence between the input cost and the output returns for the
production of a unit. Considering that input variables can
be divided in variable and ﬁxed costs, an enterprise budget
analysis can be expressed with the following equation (Eq.
(4)):
Enterprise proﬁts = output − variable costs − ﬁxed costs
(4)
EBA indicates the proﬁtability of the pig unit. For this study,
it was considered that a farm affected by PMWS  will pro-
duce six different types of units (H-S, nonPCV2-D, PMWS-D,
PMWS-R, Sub-D and Sub-S). An EBA was calculated to indi-
cate the proﬁts or deﬁcit normally obtained for each type
of unit produced.
Rushton (2009) described PBA as a “technique used to
assess small changes in farming systems, a livestock sec-
tor enterprise or an existing organization”. It compares the
extra costs and extra beneﬁts of a change to indicate if the
change is beneﬁcial or if, on the other hand, the change is
disadvantageous. The PBA was conducted using the follow-
ing equation (Eq. (5)):Net value = (Cost saved + Extra revenue)  − (Extra cost
+ Revenue forgone) (5)
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In this study, we considered that a H-S pig would be
the normal unit produced by a farmer free of PMWS.
However, when a farm is affected by PMWS,  the farm would
produce some PMWS-D, PMWS-R, Sub-D and Sub-S pigs
instead of some H-S pigs. A PBA was therefore conducted to
estimate the extra beneﬁts and extra costs of producing dis-
eased pigs instead of H-S pigs. The net value obtained would
represent the real cost of producing each type of diseased
pig for the farmer.
Both methods, EBA and PBA, used the same data in dif-
ferent ways, with the exception that ﬁxed costs were not
included in the PBA. For example, the revenue obtained by
selling the carcass of an H-S pig is estimated in £108.39.
In an EBA this value appeared as a ‘revenue’ estimate for
H-S pig. In a PBA this value appeared as a ‘revenue forgone’
estimate for a PMWS-D and for a Sub-D. In this study, the
data obtained from the EBA was used to perform a PBA in
order to estimate the extra (or marginal) beneﬁts and extra
(or marginal) costs of producing each type of diseased pig
instead of a H-S pig.
For the EBA, the feed cost of a pig was obtained by
multiplying the total feed consumption of the pig with
the price of grower feed. Total feed consumption of a H-S
pig was estimated by multiplying the feed conversion rate
(obtained from the 2010 benchmarking data using only the
top third farms), with the total weight gain of this pig. Feed
consumption of diseased pigs were calculated using the
daily feed consumption rate, the corresponding days in feed
and taking into account the appetite loss of PMWS  pigs or
the average reduction in daily feed consumption of subcli-
nical pigs. These two latter parameters were obtained from
the analysis of the L-2001 study as described in Section
2.2.1.1 and in Appendix 1.
In the EBA, transport costs, levy payments, insurance
and inspection costs were only applied to pigs reaching
slaughter. Calculation of the veterinary care and treatment
(Vet&Med) cost for PMWS  pigs was done using a vet-
erinary multiplication factor, obtained from the FO-2011
study, which was multiplied to the reference Vet&Med cost
of a H-S pig (see Table 4 footnote). Other variable costs
(Vet&Med for subclinical pigs, and electricity, water and
bedding costs for all pigs) were calculated according to a
pig’s time present on the farm. For the EBA, ﬁxed costs were
considered constant for all types of pigs.
2.3.2. Farm level economic analysis
Results from the individual PBAs were combined with
the disease model’s estimates of the proportion of differ-
ent pigs produced at different severity scores to assess the
total cost of PMWS (PMWS-D + PMWS-R) and PCV2SI (Sub-
D + Sub-S) at farm level. The combined PMWS  and PCV2SI
cost was also calculated for each PMWS  severity score. Sim-
ilarly, results from the individual EBAs were combined to
estimate the overall proﬁt at farm level. Cost or proﬁts per
sow per year was used as the reference parameter for the
farm.2.3.3. Industry level economic analysis
The economic model was re-run by replacing the val-
ues of the economic parameters with data from the 2008
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for each farm in the CS-2008 study; as details on PMWS
severity and number of sows were known for each of the
farms. Knowing that the population fraction of the sam-
ple of farms in the CS-2008 study was 10.21%, a model
inference was  done to assess the overall disease cost of the
English pig industry for the year 2008.
In addition, an investigation of the industry cost of
PMWS  and PCV2SI for the period 2001–2007 was  done.
Average post-weaning mortality and PMWS  morbidity per
year for the period 2001–2007 were collected for each farm
during the CS-2008 study. Although PCV2 prevalence for
these farms and for this period was missing, it was esti-
mated by identifying the most likely PCV2 prevalence for
a given combination of post-weaning mortality and PMWS
morbidity, through linear regression of 2008 data. By com-
bining these three variables, a pseudo-PMWS severity score
was calculated for each farm and for each year using the
equations from Alarcon et al. (2011b). In order to reduce the
risk of misclassiﬁcation, the pseudo-PMWS severity score
was only calculated for farms that passed the misclassiﬁ-
cation process described in Alarcon et al. (2011b). Data of
average number of sows for each farm and each year were
also available from the CS-2008 study. The aggregate num-
ber of sows of the farms in the CS-2008 study for each year
was used to calculate the population fraction of the sample
for the corresponding year. Data on production perfor-
mance, cost and prices for each year were obtained from the
benchmarking results published in the corresponding year-
book (Bench01 to Bench08). The economic model was  then
run and the total combined PMWS  and PCV2SI industry cost
for each year for the period 2001–2007 was estimated.
2.4. Stochastic simulation and sensitivity analysis
Stochastic simulation was  performed using @RISK soft-
ware for Excel version 5.0 (Palisade corporation, Newﬁeld,
New York, USA). Distributions were ﬁtted to variables that
had some degree of variability or uncertainty (Table 2),
and the model was  run with 10,000 iterations. Variables
believed to have a high impact on the model were assessed
in the sensitivity analysis, where variables were changed
10% upwards and downwards from their baseline value.
Mean was  chosen as reference when the variable output
was normally distributed. If variable output was  non para-
metric, the median was selected.
3. Results
3.1. Epidemiological model
Analysis of the L-2001 data identiﬁed that PCV2 infected
pigs that developed PMWS  clinical signs had a 26% reduc-
tion in average daily gain compared to non-PCV2 infected
pigs (p-value < 0.01). Also, PCV2 infected pigs that did
not show PMWS  clinical signs, had a signiﬁcantly lower
ADG than non-PCV2 infected pigs (16% ADG reduction, p-
value < 0.01). Therefore it was  estimated that PMWS-R pigs
require an extra 33.3 days on the farm to reach the slaugh-
ter weight of 102.6 kg, and a Sub-S pig needs 26.7 extra
days. Furthermore, it was  observed that 73% of the PCV2
infected pigs that did not show PMWS  clinical signs had an
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Fig. 2. Percentages of each type of pig in a batch at different PMWS severity levels. Where: H-S are healthy pigs with normal growth; PMWS-D are PMWS
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tigs  that die due to the disease; PMWS-R are PMWS  pigs that recover from the d
linical sign and that die; Sub-S are PCV2 infected pigs with slow growth, no clea
ue  to non PCV2 related causes.
able 4
esults from the enterprise budget analyses. Mean values from the stochastic mod
re  PMWS pigs that die due to the disease; PMWS-R are PMWS  pigs that recover f
MWS  clinical sign and that die; and Sub-S are PCV2 infected pigs with slow grow
Value (£)
H-S 
Revenue Total deadweight solda 108.39 
Depreciation of sowb −3.54 
Variable costs Sow feedc −9.12 
Pig  feedd −45.75 
Vet&Med coste −1.87 
Transportf −2.34
Carcass disposal 0 
Electricityg −2.12 
Waterg −0.60 
Straw  & beddingg −0.43 
Levy,  insurance, inspectionh −2.90 
Gross  marginj 39.72 
Fixed  costs Labouri −10.83 
Buildingi −3.47 
Equipmenti −3.51 
Other  ﬁxed costsi −2.68 
Net  marginj 19.23 
a Assuming that the deadweight of a pig is 76% of its live weight (English et al
APP  to the carcass weight at slaughter. For PMWS-R pigs a penalty cost (PC, see
b Depreciation of a sow was  calculated as: CG/(AP*WSY).
c Sow feed cost was  calculated as: (FQS*FPS)/WSY.
d Feed cost was estimated multiplying the quantity of feed consumed by each t
e The cost of Veterinary care and Medical treatment (Vet&Med) was 2.4 pp per 
y  multiplying this with the total deadweight at slaughter. The Vet&Med cost fo
ig  by the VMF. The Vet&Med cost for PMWS-R was derived by summing two c
he  time spent in the farm after recovering from disease (extrapolated from the H
xtrapolating the cost obtained for a H-S pig according to their days in feed.
f Obtained from Bench09 for H-S, PMWS-R and Sub-S pigs.
g Reference cost for a H-S pig was obtained from Bench09. Costs for diseased a
h Reference cost for a H-S pig was obtained from Bench10. Only pigs sent to sla
i The cost of labour was  £13.9 per kg deadweight (Bench10). This was  multipl
ere  obtained from Bench09. Fix costs were assumed constant for each type of p
j Gross and net margin values in this table correspond to the mean values obtai
o  the exact calculations from the above values.isease; Sub-D are PCV2 infected pigs with slow growth, no clear PMWS
r PMWS  clinical sign and that survive; and nonPCV2-D are pigs that die
el are shown. Where: H-S are healthy pigs with normal growth; PMWS-D
rom the disease; Sub-D are PCV2 infected pigs with slow growth, no clear
th, no clear PMWS  clinical sign and that survive.
PMWS-D PMWS-R Sub-D Sub-S
0 99.29 0 108.39
−3.54 −3.54 −3.54 −3.54
−9.12 −9.12 −9.12 −9.12
−15.28 −49.81 −19.08 −49.05
−6.24 −7.82 −0.87 −2.24
0 −2.34 0 −2.34
−6 0 −6 0
−0.85 −2.64 −0.98 −2.54
−0.24 −0.75 −0.28 −0.72
−0.17 −0.53 −0.20 −0.52
0 −2.90 0 −2.90
−41.94 19.85 −40.07 35.42
−10.83 −10.83 −10.83 −10.83
−3.47 −3.47 −3.47 −3.47
−3.51 −3.51 −3.51 −3.51
−2.68 −2.68 −2.68 −2.68
−61.64 −0.65 −60.57 14.92
., 1988). The carcass value of a pig was then obtained by multiplying the
 Table 2) was subtracted for each deadweight kg at slaughter.
ype of pig with FPG.
kg deadweight (Bench10). Therefore, the cost for a H-S pig was obtained
r PMWS-D was  calculated by multiplying the value obtained for an H-S
osts: Vet&Med cost of a PMWS-D pig + the equivalent Vet&Med cost for
-S cost). The Vet&Med cost for a Sub-D and a Sub-S pig was obtained by
nimals were obtained by extrapolating according to their days in feed.
ughter are subject to this cost.
ied by the deadweight of a H-S pig. Building, equipment and other costs
ig.
ned after the stochastic model. Therefore, the values will not correspond
terinaryP. Alarcon et al. / Preventive Ve
ADG below the lower 95% conﬁdence interval level of an
H-S pig. The parameter values needed for the epidemio-
logical and economic model are summarised in Table 2.
Outline and results of the epidemiological model after
data ﬁtting are presented in Figs. 1 and 2, respectively.
The model found that PCV2 subclinical pigs are present
at any PMWS severity category, as PCV2 prevalence of
slightly affected farms never reaches zero. Further, at all
severity levels the number of PCV2 subclinical pigs (Sub-
d + Sub-S) was always higher than the number of PMWS
pigs (PMWS-D + PMWS-R). The use of exponential func-
tions to ﬁt the data is reﬂected in the number of H-S pigs
decreasing exponentially as severity increases. The pro-
portion of H-S pigs in an average slightly, moderately and
highly affected farm was 85.9%, 74.9% and 61.21% respec-
tively.
3.2. PMWS  economic model
3.2.1. Individual economic analysis
Results from the EBAs are summarised in Table 4. The
EBA analysis showed that a farmer has a mean deﬁcit of
£-61.6 (90% CI: −67.0 to −57.5) for each PMWS-D pig, £-
0.7 (90% CI: −10.6 to 7.9) for each PMWS-R pig, and £-60.6
(90% CI: −65.3 to −56.0) for each Sub-D pig, but will be able
to make a proﬁt of £14.9 (90% CI: 11.2–18.1) for each Sub-S
pig.
Results from the PBAs, which compared the extra cost
and extra beneﬁt of producing a diseased pig instead of a H-
S pig, are summarised in Table 5. The PBA shows a marked
negative net value for those pigs that died (PMWS-D and
Sub-D). The mean net value per PMWS-D pig were £-84.1
(90% CI: −89.1 to −79.6), £-24.6 (90% CI: −35.4 to −15.1)
for a PMWS-R pig, £-82.7 (90% CI: −87.5 to −78.1) a Sub-D
pig, and £-8.1 (90% CI: −15.1 to −2.2) for a Sub-S pig.
3.2.2. Farm level economic analysis
By combining the results from the individual economic
analysis (PBAs) with the proportion of each type of pig
at different severities, the overall farm cost of PMWS  and
PCV2SI for a farm was estimated (Figs. 3 and 4). At farm
level, the cost due to PCV2SI was higher than the cost of
PMWS pigs at all severity levels. The mean of the combined
PMWS and PCV2SI cost for an average slightly, moderately
and highly affected farm was £-21.0 (90% CI: −38.9 to −6.3),
£-107.5 (90% CI: −142.8 to −75.1) and £-244.7 (90% CI:
−313.2 to −179.0) per sow per year, respectively. The pro-
ﬁtability of a farm became negative when PMWS  severity
score was nine (90% CI: 8.5–9.5).
3.2.3. Economic analysis at industry level
Model inference indicated that the total combined
PMWS and PCV2SI cost for the English pig industry for
the year 2008, before implementation of PCV2 vaccina-
tion, was £55.7 million (90% CI: 37.8–77.1). Details of
the total cost of PMWS and PCV2SI for previous years
were estimated using PMWS  pseudo-severities and are
summarised in Fig. 5. The overall combined PMWS/PCV2SI
cost for the period 2001–2007 was £551.1 million (90% CI:
503.5–598.6). Medicine 110 (2013) 88– 102 97
3.3. Sensitivity analysis
Sensitivity analysis indicated that the most inﬂu-
ential variables in the model were, in order of
importance: (1) post-weaning mortality regression
coefﬁcient (total farm cost for an average highly
affected farm (TCH) ranged between £199.4 and
£297.0/sow/year), (2) price per deadweight kg (TCH
range = £208.3–283.4/sow/year), (3) average daily gain
of a H-S pig (TCH range = £212.1–279.5/sow/year), (4)
number of piglets born alive per sow per year (TCH
range = £219.8–271.9/sow/year), (4) litters per sow per
year (TCH range = £220.2–271.5/sow/year), (5) feed con-
sume per H-S pig (TCH range = £236.1–255.6/sow/year),
(6) grower feed price per tonne (TCH
range = £236.1–255.7/sow/year), (7) percentage
reduction in average daily gain in subclini-
cal pigs (TCH range = £234.9–251.3/sow/year),
(8) PCV2 prevalence regression coefﬁcient (TCH
range = £238.5–252.6/sow/year), (9) pre-weaning mor-
tality (TCH range = £242.1–249.6/sow/year) and (10)
reduction in feed consumption of PCV2 subclinical pigs
(TCH range = £242.5–249.2/sow/year). Due to the usual
high variability of the price per kilogram deadweight
(DAPP) and the fact this was the second most important
variable identiﬁed in the sensitivity analysis; further
analysis was done by running the model with different
values of DAPP. Results showed that proﬁtability of the
farm was  the outcome most affected (Fig. 6).
4. Discussion
Post-weaning multi-systemic wasting syndrome is
probably one of the most economically damaging diseases
for the pig industry worldwide in the last 15 years. To our
knowledge this is the ﬁrst study that uses empirical data,
at farm and animal level, to estimate the economic impact
of PMWS  and PCV2SI. The results indicate the extent of
the economic impact of this disease in farms with different
PMWS  severities and the historical economic impact for the
whole English pig industry, which was found to be higher
than previously estimated (Armstrong and Bishop, 2004).
This is mainly because previous studies did not consider
the losses caused by subclinical infection, which economic
importance was  clearly highlighted in our study. Although
the model was  based on several assumptions, most of these
critical points were addressed through the stochastic sim-
ulation.
The approach used for the economic model accounted
for the epidemiological complexity of PMWS.  In an
endemic situation where severity of the disease varies
highly between farms, the PMWS  severity score proved
useful tool to capture this variability. The three compo-
nents of this severity score increased exponentially, which
was the reason why exponential equations were used to ﬁt
the data to the model. However, the variability of each of
the components within a PMWS  severity score was higher
as the severity increases, indicating that different PMWS
disease scenarios were present in highly affected farms. It
is also important to mention that only one farm in the cross-
sectional study had a PMWS  severity score higher than 8.30
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Table 5
Results from the partial budget analyses. Mean values from the stochastic model are shown. Where: H-S are healthy pigs with normal growth; PMWS-D
are  PMWS pigs that die due to the disease; PMWS-R are PMWS  pigs that recover from the disease; Sub-D are PCV2 infected pigs with slow growth, no clear
PMWS  clinical sign and that die; and Sub-S are PCV2 infected pigs with slow growth, no clear PMWS  clinical sign and that survives.
Value (£)
PMWS-D PMWS-R Sub-D Sub-S
Extra cost Extra pig feeda 0 −4.06 0 −3.31
Extra  Vet&Med costsb −4.37 −5.95 0 −0.37
Extra  electricityb 0 −0.52 0 −0.42
Extra  waterb 0 −0.15 0 −0.12
Extra  straw & beddingb 0 −0.10 0 −0.09
Extra  levy, insurance, inspection costsb 0 0 0 0
Carcass disposalb −6 0 −6 0
Revenue forgone Deadweight not sold −108.39 0 −108.39 0
Loss  in carcass qualityc 0 −9.10 0 0
Proﬁt  lost due to miss-used spaced 0 −4.58 0 −3.66
Total  extra costs −112.76 −24.34 −114.39 −13.86
Costs  saved Pig feed saveda 30.47 0 26.66 0
Vet&Med costs savedb 0 0 1.00 0
Electricity savedb 1.27 0 1.14 0
Water savedb 0.36 0 0.32 0
Straw & bedding savedb 0.26 0 0.23 0
Extra  levy, insurance, inspection costs savedb 2.90 0 2.90 0
Transport savedb 2.34 0 2.34 0
Extra revenue None − − − −
Total  beneﬁts 37.60 0 32.43 0
Net  totale −84.06 −24.55 −82.69 −8.11
a Differences in feed consumed, compared to a H-S pig, were multiplied by FPG.
b Difference in cost compared to a H-S pig.
c Carcass weight of a PMWS-R pig at slaughter was multiplied by PC (see Table 4).
d Calculated only for PMWS-R and Sub-S pigs because of their extra days in feed on the farm. The space they occupied could have been used to improve
the  productivity of the farm. To account for this loss of potential, the proﬁts obtained for each H-S pig produced in 140 days was extrapolated to the extra
days  in feed that these disease pigs remained on the farm.
e Net margin values in this table correspond to the mean values obtained after the stochastic model. Therefore, the values will not correspond to the
exact  calculations from the above values.
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s less reliable for high severity levels. Nevertheless, it was
seful in estimating the cost of PMWS  during the epidemic
eriod, where many farms would have had such a high
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This study indicates the high farm level cost of PMWS
nd PCV2SI to pig producers, from which the lattere PMWS  pigs that recover from the disease; Sub-D are PCV2 infected pigs
nfected pigs with slow growth, no clear clinical sign and that survive.
represent the major cost. The importance of these PCV2
subclinical pigs is now widely accepted, in particular since
the use of PCV2 vaccines improved productivity of farms
more than could be expected by eliminating clinical dis-
ease only (Kurmann et al., 2011; Segales, 2011a; Young
et al., 2011). The results obtained from the longitudinal
study (LS-2001) conﬁrmed the impact of this condition on
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Straight  lines shows the mean values and the dotted lines correspond to 
the growth rate of the pigs and provided useful estimates
for the economic model. However, the exact proportion
of subclinical pigs on the farms from the cross-sectional
study (CS-2008) was difﬁcult to estimate and, to our knowl-
edge, no data is present in the existent literature. Therefore,
the model operated with the results from the L-2001study
which identiﬁed that 73% of non-PMWS PCV2 infected
pigs developed subclinical conditions (slow growth). How-
ever, the current model does not account for the overall
cost of PCV2 as other syndromes caused by this pathogen
were not accounted for, namely porcine dermatitis and
nephropathy syndrome or PCV2 associated reproductive
disorder. This is due to the fact that morbidity data col-
lected on the farm only focused on PMWS  and not on
other PCV2 syndromes. Yet some of the subclinical pigs
that die in this model would have died due to other PCV2
syndromes, and therefore were accounted for to some
degree.Another important factor believed to trigger onset of
PMWS is co-infection with other pathogens (Krakowka
et al., 2000; Pogranichniy et al., 2002; Opriessnig et al.,
Fig. 5. Total combined PMWS  and PCV2SI cost for the whole English pig indust
Benchmarking data for the years 2001 to 2008 was  used for the following para
pre-weaning mortality, (4) sow feed price per tonne, (5) grower feed price per to
per  pig, (8) Straw & Bedding cost per pig, (9) transport cost per pig, (10) miscella
pig,  (13) equipment cost per pig, (14) other ﬁxed cost per pig, (15) deadweight avifferent PMWS  severity levels using 2010 data (stochastic model output).
conﬁdence intervals.
2004; Wellenberg et al., 2004; Dorr et al., 2007; Alarcon
et al., 2011a). These other pathogens will also have more
opportunity to cause harm as the number of subclini-
cal pigs, and therewith pigs with increase susceptibility,
increases. This might explain the exponential rise of death
of these pigs as PMWS  severity increases. Because these
deaths might be due to the higher susceptibility caused by
PCV2 infection, their economic impact were accounted in
the model and attributed to PCV2 subclinical pigs. On  the
other hand, farms with low PMWS  severity scores are likely
to be free of other major pathogens, similar to high health
farms. Although some of the costs due to other diseases
might have been involuntarily accounted for, the model is
believed to mainly represent the economic impact of the
increase in PMWS  severity in a farm.
The total estimated PMWS  impact for each year during
the epidemic phase (2001–2004) was  approximately £88
million, a higher value than previous estimations which did
not cover the overall impacts of the disease (Armstrong
and Bishop, 2004). This new cost estimate and the ﬁgure
related to the aggregated cost of the disease for the period
ry from 2001 to 2008. (*) Based on pseudo-PMWS severity estimations.
meters: (1) litters per sow per year, (2) piglets born alive per litter, (3)
nne, (6) Vet & Med  cost per pig, (6) Electricity cost per pig, (7) Water cost
neous or LII cost per pig, (11) labour cost per pig, (12) building cost per
erage price per kg and (16) number of breeding sows.
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pig. 6. Costs of PMWS,  cost of PCV2SI and proﬁtability of the farm at diffe
ritten above its ‘total proﬁt’ line.
001–2007 are important to contextualize the amount of
esearch and intervention done on this disease during this
eriod, and to understand the economic impact that novel
iseases could have in an industry. Although there were
ewer farms affected in the epidemic years than during
ndemic years, their PMWS  severity score was higher. The
ig population in England was also higher during the epi-
emic years, which further contributed to the increased
ost of the disease. However, the sampling population frac-
ion of the farms with reliable data for these years was
ow (2–7%) and representativeness is questionable. More-
ver, because of the lack of serum samples for the period
001–2007, only pseudo-severities could be calculated.
herefore, although these historical economic results may
rovide a closer understanding to the real cost of PMWS
or the epidemic years than previous studies, these should
e interpreted with caution. On the other hand, the data
btained from 2008 cross-sectional study is believed to be
epresentative of the English pig industry. Although many
f the farms in the CS-2008 study were recruited through
he BPEX PCV2 vaccination scheme, and were therefore
ore likely to be moderately or highly affected by PMWS,
he recruitment of other farms not participating in this
cheme, through veterinary practitioners, reduced the farm
election bias and therefore increased the representative-
ess of the sample. Further the industry sample fraction
f the 2008 data (10.2%) and the spatial distribution of
he farms that participated in the CS-2008 study (data
ot shown) indicate a good representation of the English
ig industry. Nonetheless, it is important to note that the deadweight kilogram prices (DAPP) values. The corresponding ‘DAPP’ is
industry analysis performed in this study did not account
for price ﬂuctuations in relation to supply and demand. In
theory, the increase in production costs and the decrease
in productivity due to PMWS/PCV2SI would have caused
prices to rise. This effect would be felt unevenly across
the industry depending on whether an individual opera-
tion was affected by PCV2 or not. Non-affected operations
would beneﬁt from the price increases and increased pro-
ﬁtability, somewhat offsetting the losses and cost increases
incurred by affected operations. Consumers would also be
negatively impacted by the changes in price. Overall, it is
possible that an overestimation of the cost of the disease at
industry level might have occurred.
The economic tools used for this analysis, enterprise
budget analysis and partial budget analysis, are widely used
in animal health economics. Both analyses provided dif-
ferent types of information that are relevant to producers.
The EBA indicates what is the actual proﬁt or deﬁcit of pro-
ducing each type of pig. This information is relevant as it
helps to understand the impact of the disease to the eco-
nomic situation of the farm, such as cash ﬂow effects and
overall proﬁtability. On the other hand, PBA indicates the
real cost of the disease, as it shows the losses incurred
by producing diseased pigs instead of healthy pigs. The
economic structure used for the enterprise budget analysis
was  based on the structure provide by BPEX, the English
pig levy payer association, in their pig yearbook journals.
However, a proportion of the labour cost can normally be
classiﬁed as variable cost, when part of the payment is sub-
jected to productivity of the farm or extra hours needed
terinaryP. Alarcon et al. / Preventive Ve
(Rushton, 2009). Yet, due to the uncertainty of the possible
variable cost associated with labour in relation to PMWS,
further investigation was done during the FO-2011 study.
Most of the farmers in this study declared that, although
they had to work more due to PMWS,  no extra labour fee
was normally paid (data not shown). Consequently, labour
was maintained as a ﬁxed cost in this study. Nonetheless,
further investigation into the opportunity cost due to the
extra labour would allow the model to give even more
precise estimations of the true cost of PMWS.  Similarly,
disease impact on the other ﬁxed cost parameters was  not
accounted in this model, and therefore some underestima-
tion might have occurred in this regard.
Several of the parameters used to assess the cost of dis-
ease were based on pig industry benchmarking data. This
data only includes farms using Agrosoft recording software
and might have lead to some bias in the estimation of some
parameters. Using the top third farms benchmarking data
to inform some parameters for the growth and feed intake
of H-S pigs was based on the assumption that these farms
would be more likely to be free of diseases and, therefore, to
have values most representative of H-S pig. However, these
farms could also have signiﬁcant differences in manage-
ment, breed or farm structure compare to average farms.
Therefore, some bias might have occurred. Furthermore,
ﬁxed costs were assumed to be the same for all farms in
the study. The online accessible version of the model how-
ever, allows farmers to input their own speciﬁc values (e.g.
H-S pig production values, ﬁxed costs, etcetera).
Several other biases and limitations need to be consid-
ered when interpreting the ﬁndings. The most important
is related to the PCV2 prevalence estimation at farm level
which was obtained through stratiﬁed sampling of pigs
in the cross-sectional study by age matching of PMWS
affected and healthy pigs in each age group. Although
the proportion of PCV2 PCR positive pigs provides a good
contributing indicator of PMWS  severity, its use as PCV2
within-farm prevalence estimate might have resulted in
an overestimation or underestimation of the real num-
ber of infected pigs on the farm. However, the fact that
apparently healthy pigs were also consistently included in
the sample may  relax somewhat this overestimation, and
the combined results, from PMWS  and health pigs, may
be considered as a reasonable approximation of the real
prevalence. This model also assumed that no compensatory
growth occurred on PMWS-R pigs after recovering from
the disease. The compensatory growth effect in pigs has
been described by several authors after an abrupt transition
of feed composition and feeding regime given to growing
pigs (Heyer and Lebret, 2007). However, to the authors’
knowledge, this effect has not been reported as a sign of
recovering from PMWS.  Nonetheless, it is possible that an
overestimation of the extra costs associated to these pigs
might have occurred due to this assumption.
The current study provides a useful decision support
tool to illustrate farmers about the costs of a typical pro-
duction disease (http://www.bpex.org.uk/R-and-D/R-and-
D/PMWSEpidemiology.aspx). This economic model further
will be used to investigate the efﬁciency of different con-
trol measures through investment appraisal and a scenario
analysis. Medicine 110 (2013) 88– 102 101
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